Alison Taylor Schmitz
Nurse Practitioner · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 4 years
- Graduated 2022
Offices
1 location · Sleep Reset Medical Group of California PC · 5 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Alison Taylor Schmitz’s office at (862) 235-4743 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$2,947
Medicare paid this office $2,947 for 52 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Biopsy and aspiration of bone marrow sample for diagnosis | 33 | $1,592 | $48 |
Procedures year by year
| Procedure | 2023 | 2024 |
|---|---|---|
| Biopsy and aspiration of bone marrow sample for diagnosis | 13 | 33 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
52 Original Medicare patients in 2024. Average age 74 · Women 48% · Also on Medicaid 23% · Health risk score 3.42. Sicker patients than 9 in 10 peers; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 38% · Chronic kidney disease 38% · Heart failure 27% · Diabetes 25% · Atrial fibrillation 25% · Depression 21%.
The office billed $43,710, Medicare allowed $4,325 and paid $2,947; for 56 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 52 | 56 | 74 | 3.42 | $43,710 | $2,947 |
| 2023 | 29 | 30 | 71 | 1.65 | $18,516 | $1,722 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Biopsy and aspiration of bone marrow sample for diagnosis | 13 | $698 | $54 |
Drugs they prescribed that Part D paid
$1,697,897
Pharmacies billed $1,697,897 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (18 of 341) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
205 generic and 136 brand-name prescriptions · $1,697,897 in drug cost · 25 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Revlimid | 16 | $305,802 | $19,113 |
| Jakafi | 13 | $223,564 | $17,197 |
| Pomalyst | 11 | $223,098 | $20,282 |
| Calquence | 12 | $186,067 | $15,506 |
| Brukinsa | 17 | $179,218 | $10,542 |
See all 11 drugs
| Revlimid | 16 | $305,802 | $19,113 |
| Jakafi | 13 | $223,564 | $17,197 |
| Pomalyst | 11 | $223,098 | $20,282 |
| Calquence | 12 | $186,067 | $15,506 |
| Brukinsa | 17 | $179,218 | $10,542 |
| Lenalidomide | 11 | $153,458 | $13,951 |
| Eliquis | 24 | $24,285 | $1,012 |
| Acyclovir | 68 | $1,456 | $21 |
| Hydroxyurea | 16 | $788 | $49 |
| Dexamethasone | 18 | $238 | $13 |
| Sulfamethoxazole-Trimethoprim | 18 | $99 | $5 |
Money from drug and device companies
$646 in 2024
| 2024 | 11 | 16 | None | $646 |
| 2023 | 6 | 10 | None | $546 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Venclexta | $244 | 3 payments
|
| GlaxoSmithKline | Ojjaara | $124 | 1 payment
|
| Rigel Pharmaceuticals | Rezlidhia | $57 | 3 payments
|
| Merck Sharp & Dohme | Keytruda | $48 | 2 payments
|
| Janssen Biotech | Darzalex | $36 | 1 payment
|
| Celgene | Pomalyst | $29 | 1 payment
|
See all 16 published payments
| PharmaEssentia USA | Meals · 2024-12-17 | Besremi | $21 |
| Janssen Biotech | Meals · 2024-08-27 | Darzalex | $36 |
| Merck Sharp & Dohme | Meals · 2024-07-12 | Keytruda | $23 |
| Kite Pharma | Meals · 2024-05-31 | Yescarta | $22 |
| Servier Pharmaceuticals | Meals · 2024-05-28 | Tibsovo | $24 |
| Incyte | Meals · 2024-05-25 | Jakafi | $18 |
| Merck Sharp & Dohme | Meals · 2024-04-23 | None | $25 |
| Celgene | Meals · 2024-04-17 | Pomalyst | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2024-04-16 | Calquence | $22 |
| Abbvie | Meals · 2024-04-09 | Venclexta | $125 |
| Abbvie | Meals · 2024-03-26 | Venclexta | $88 |
| Abbvie | Meals · 2024-03-19 | Epkinly | $31 |
| GlaxoSmithKline | Meals · 2024-03-06 | Ojjaara | $124 |
| Rigel Pharmaceuticals | Meals · 2024-03-05 | Rezlidhia | $29 |
| Rigel Pharmaceuticals | Meals · 2024-01-23 | Rezlidhia | $2 |
| Rigel Pharmaceuticals | Meals · 2024-01-23 | Rezlidhia | $26 |
See earlier years (2023)
2023: $546
| E.R. Squibb & Sons L.L.C. | Reblozyl | $237 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Calquence | $150 | 2 payments
|
| Janssen Biotech | Darzalex | $63 | 2 payments
|
| Kite Pharma | Yescarta | $50 | 2 payments
|
| Rigel Pharmaceuticals | Rezlidhia | $25 | 1 payment
|
| GlaxoSmithKline | Ojjaara | $20 | 1 payment
|
Professional record
- NPI
- 1225750904
- Licence
- CA 95022678
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2022-09-19
- NPI last updated
- 2023-03-14
- NPI record certified
- 2023-03-14
This is when the NPI record was last certified, not a medical board exam.